Product Banner

World Neuroprosthetics Market - Opportunities and Forecasts, 2013 - 2020

World Neuroprosthetics Market - Opportunities and Forecasts, 2013 - 2020
$4,515.00
$4,515.00
  • Nov 25, 2014
  • 156 pages
  • Allied Market Research
Abstract
Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the ‘quality-of-life’ of the affected patient populace. The Neuroprosthetics, as therapeutic modalities, are emerging as a promising option in cases where all conventional treatments fail to deliver results/treatment to the disease condition. Improvement in the ‘quality-of-life’ of the affected patients, high availability of funds for R&D of Neuroprosthetics from the Government (public) and private sector investments in turn aid development of newer and improved variants of Neuroprosthetics - all result in increased uptake by the patients. Thus, the afore-mentioned are key drivers of the Neuroprosthetics market; however, reimbursement issues and high cost of Neuroprosthetics/devices are the restraints to the market growth. Owing to the high-impact growth drivers that outweigh the restraints, the global neuroprosthetics market is forecast to reach $14 billion by 2020, registering a CAGR of 15.8% from 2014 to 2020.

The global neuroprosthetics market is segmented based on technology, types, applications and geography. The Neuroprosthetics’ Mechanism Of Action (MOA) varies as per underlying technology; hence, Neuroprosthetics can also be classified by technology into - Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS) and Sacral Nerve Stimulation (SCS). Various types of Neuroprosthetics have been developed based on the application areas, i.e., the disease condition treated, for example, Motor Neuroprosthetics – treat motor neuron disorders such as Parkinson’s disease, Epilepsy, Auditory Neuroprosthetics/ Cochlear implants – treat hearing disorders; Visual Neuroprosthetics/ Retinal implants – treat visual impairment; and Cognitive Neuroprosthetics - treat Alzheimer’s disease, and severe depression. Visual Neuroprosthetics/ Retinal implants, is the fastest growing (CAGR 31.5%) Neuroprosthetics segment, owing to high-impact growth attribute of improving ‘quality-of-life’ of visually impaired patients. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.

Developing bio-compatible, sensitive and safe products are the keys to success in the global Neuroprosthetics market. In tune with this, many companies across the world are involved in the R&D of newer and multitude of variants of Neuroprosthetics’ product lines and is seeking regulatory approval and commercialization. Few of such companies are profiled in the report - Medtronic Inc., MED-EL, Advanced Bionics AG, Boston Scientific Corporation, Biomet, Inc., St. Jude Medical, Retina Implant AG, NeuroPace, Inc. and NDI Medical LLC.

Neuroprosthetics Side bar

KEY BENEFITS

An in-depth analysis of the current market scenario, future market estimates and trend-analysis – to reveal holistic picture that in turn facilitates decision making
Quantitative analysis of the current market and estimations through 2013-2020 - to assist corporate strategists to design business strategies to capitalize on the current and future (possible) opportunities in the market
Strategic analysis of key market players and business strategies within the global market provided - would assist stakeholders to make informed business decisions
Pinpoint intelligence of key investment pockets are illustrated from the manufacturers point of view
Report emphasizes on the key strategies adopted by the giants operating in the neuroprosthetic devices market
Technological trends of neurological devices are critically analyzed and validated through primaries
Identification of key product segments based on current and potential growth prospects - to reveal most profitable segments that can be catered to by the market players
MARKET SEGMENTATIONThe global neuroprosthetics market is segmented according to / by - technology, type, application, and geography.

MARKET BY TECHNOLOGY

Deep Brain Simulation (DBS)
Vagus Nerve Stimulation (VNS)
Spinal Cord Stimulation (SCS)
Sacral Nerve Stimulation (SNS)
MARKET BY TYPE

Motor Neuroprosthetics
Auditory Neuroprosthetics/ Cochlear implants
Visual Neuroprosthetics/ Retinal implants
Cognitive Neuroprosthetics
MARKET BY APPLICATION

Motor Neuron disorders
Parkinson's disease
Epilepsy
Physiological disorders
Auditory disorders
Ophthalmic disorders
Neurocardiac disorders
Over Active Bladder syndrome (kidney disorders)
Cognitive disorders
Alzheimer's disease
Severe depression
MARKET BY GEOGRAPHY

North America
Europe
Asia-Pacific
LAMEA
Table of Contents
Chapter: 1 INTRODUCTION
1.1 Report Description

1.2 Key Benefits

1.3 Key Market Segments

1.4 Key Audiences

1.5 Research Methodology

1.5.1 Primary Research

1.5.2 Secondary Research

1.5.3 Analyst tools and models



$0(SU)
Chapter: 2 EXECUTIVE SUMMARY
2.1 Market beyond what to expect by 2025 ($Million)

2.1.1 Moderate growth scenario

2.1.2 Rapid growth scenario

2.1.3 Diminishing growth scenario



$176(SU)
Chapter: 3 MARKET OVERVIEW
3.1 Market Definition and Scope

3.2 Addressable Market Scenario

3.3 Ethical Considerations

3.4 Key Findings

3.4.1 Top Factors Impacting on global neuroprosthetics market

3.4.2 Top Investment Pockets of global neuroprosthetics market

3.4.3 Top winning strategies of global neuroprosthetics market

3.5 Advances in neuroprosthetic implantation

3.5.1 Stereotactic implantation

3.5.1.1 Historical Perspective

3.5.1.2 Current Trends

3.5.1.2.1 INCREASING USE OF MRI, CT SCANS AND OTHER IMAGE GUIDING SYSTEMS FOR STEREOTACTIC IMPLANTATION

3.5.1.2.2 ROBOTS FOR IMPROVED STEREOTAXIC PRECISION

3.5.1.3 Competitive scenario

3.5.2 Electrophysiological mapping

3.5.2.1 Historical Perspective

3.5.2.2 Current Trends

3.5.2.2.1 EVOKED POTENTIAL MONITORING

3.5.2.2.2 SINGLE-UNIT RECORDINGS

3.5.2.3 Competitive scenario

3.6 Government Regulations

3.6.1 Medical Devices regulations in United States (U.S.)

3.6.2 Medical Devices regulations in Europe and UK

3.6.3 Medical Devices regulations in Asia-Pacific

3.6.4 Regulatory approval timeframe in different regions

3.7 Patent Analysis

3.7.1 Patent analysis by geographies (2010-2014)

3.7.2 Patent analysis based on medical condition (2011-2014)

3.8 Clinical Trials for Neuroprosthetics

3.9 Value chain analysis

3.9.1 Brain Machine interfaces and neurostimulators

3.9.2 Embedded neuroprosthetic devices/implants

3.10 Market Share Analysis

3.11 Market Dynamics

3.11.1 Drivers

3.11.1.1 Rapid progression of technology – assist in improving neuroprosthetics

3.11.1.2 New device approvals- leading towards early commercialization to achieve competitive edge

3.11.1.3 Rising burden of neurological disorders that responds to neurostimulation

3.11.1.4 Availability of Funds and research grants

3.11.2 Restraints

3.11.2.1 Reimbursement Issues – have negative impact on neuroprosthetics adoption rate

3.11.2.2 Adverse reactions- increases risk of mortality and decreases usage rate

3.11.2.3 High cost of product and therapy

3.11.3 Opportunities

3.11.3.1 Early commercialization of pipeline products assists to gain competitive advantage



$881(SU)
Chapter: 4 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013-2020, $MILLION
4.1 Deep Brain Simulation (DBS)

4.1.1 Historical Perspective

4.1.2 Current Trends

4.1.2.1 Advancement in component system

4.1.2.2 Other technological advances

4.1.3 Competitive Scenario

4.2 Vagus Nerve Stimulation (VNS)

4.2.1 Historical Perspective

4.2.2 Current trends

4.2.2.1 Direct and transcutaneous vagus nerve stimulators are gaining popularity

4.2.3 Competitive Scenario

4.3 Spinal Cord Stimulation (SCS)

4.3.1 Historical Perspective

4.3.2 Current trends

4.3.2.1 Rechargeable neurostimulation system gaining significant attention

4.3.2.1.1 RESTORE™ RECHARGEABLE NEUROSTIMULATION SYSTEM

4.3.2.1.2 EON™ NEUROSTIMULATION SYSTEM

4.3.2.1.3 PRECISION™ SPINAL CORD STIMULATION SYSTEM

4.3.3 Competitive Scenario

4.4 Sacral Nerve Stimulation (SNS)

4.4.1 Historical Perspective

4.4.2 Current trends



$998(SU)
Chapter: 5 GLOBAL NEUROPROSTHETICS MARKET BY TYPE, 2013-2020, $MILLION
5.1 Motor Prosthetics

5.1.1 Key Market Trends

5.1.2 Key growth factors and opportunities

5.1.3 Market Size and forecast

5.2 Auditory Prosthetics / Cochlear Implants

5.2.1 Key Market Trends

5.2.2 Key growth factors and opportunities

5.2.3 Market Size and forecast

5.3 Visual Prosthetics / Retinal Implants

5.3.1 Key Market Trends

5.3.2 Key growth factors and opportunities

5.3.3 Market Size and forecast

5.4 Cognitive Prosthetics

5.4.1 Key Market Trends

5.4.2 Key growth factors and opportunities

5.4.3 Market Size and forecast



$998(SU)
Chapter: 6 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013-2020, $MILLION
6.1 Motor Neuron disorders

6.1.1 Parkinson’s disease

6.1.2 Epilepsy

6.2 Physiological disorders

6.2.1 Auditory disorders

6.2.2 Ophthalmic disorders

6.2.3 Cardiac disorders

6.2.4 Kidney disorders

6.3 Cognitive disorders

6.3.1 Alzheimer's disease

6.3.2 Severe depression



$881(SU)
Chapter: 7 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013-2020, $MILLION
7.1 North America

7.1.1 Key market trends

7.1.2 Competitive scenario

7.1.3 Key growth factors and opportunities

7.1.4 Market size and forecast

7.2 Europe

7.2.1 Key market trends

7.2.2 Competitive scenario

7.2.3 Key growth factors and opportunities

7.2.4 Market size and forecast

7.3 Asia-Pacific

7.3.1 Key market trends

7.3.2 Competitive scenario

7.3.3 Key growth factors and opportunities

7.3.4 Market size and forecast

7.4 LAMEA

7.4.1 Key market trends

7.4.2 Competitive scenario

7.4.3 Key growth factors and opportunities

7.4.4 Market size and forecast



$1057(SU)
Chapter: 8 COMPANY PROFILES
8.1 Boston Scientific Corporation

8.1.1 Overview

8.1.2 Company snapshot

8.1.3 Operating Business Segments

8.1.4 Financial performance

8.1.5 Strategic moves and developments

8.1.6 SWOT analysis

8.2 Cochlear Limited

8.2.1 Overview

8.2.2 Company snapshots

8.2.3 Operating Business Segments

8.2.4 Financial performance

8.2.5 Strategic moves and developments

8.2.6 SWOT analysis

8.3 Cyberonics Inc.

8.3.1 Overview

8.3.2 Company snapshot

8.3.3 Operating Business Segments

8.3.4 Financial performance

8.3.5 Strategic moves and developments

8.3.6 SWOT analysis

8.4 Medtronic Inc.

8.4.1 Company overview

8.4.2 Company snapshots

8.4.3 Operating Business Segments

8.4.1 Financial performance

8.4.2 Strategic moves and developments

8.4.3 SWOT Analysis

8.5 NDI Medical LLC

8.5.1 Overview

8.5.2 Company snapshot

8.5.3 Operating Business Segments

8.5.4 Strategic moves and developments

8.5.5 SWOT analysis

8.6 Nervo Corp.

8.6.1 Overview

8.6.2 Company snapshot

8.6.3 Operating Business Segments

8.6.4 Strategic moves and developments

8.6.5 SWOT analysis

8.7 NeuroPace Inc.

8.7.1 Overview

8.7.2 Company snapshot

8.7.3 Operating Business Segments

8.7.4 Strategic moves and developments

8.7.5 SWOT analysis

8.8 Retina Implant AG

8.8.1 Overview

8.8.2 Company snapshot

8.8.3 Operating Business Segments

8.8.4 Strategic moves and developments

8.8.5 SWOT analysis

8.9 ST. Jude Medical&l
List of Figures
List of Tables
Companies Covered